Company name | Market Cap | Profitability rating | Gross Profit margin (LTM) | EBIT margin (LTM) | EBITDA margin (LTM) | Net Income margin (LTM) | FCF margin (LTM) | Earnings quality (FCF to Net Income) |
$8,155.2K | 4.8 | 7.9% | (958.3%) | (925.3%) | (1,013.0%) | (870.0%) | 85.9% | |
$207.3B | 7.5 | 67.5% | 28.1% | 33.1% | 27.8% | 12.9% | 46.2% | |
$66.3B | 7.2 | 59.4% | 12.9% | 17.8% | 8.5% | 14.2% | 170.0% | |
$46.6B | 7.9 | 55.6% | 14.2% | 20.5% | 10.3% | 6.1% | 129.1% | |
$34.6B | 8.9 | 57.9% | 31.7% | 33.6% | 25.3% | 28.2% | 111.2% | |
$18.6B | 7.0 | 62.8% | 18.1% | 25.9% | 10.1% | 7.4% | 73.4% | |
$17.9B | 4.3 | 37.1% | (1.1%) | 7.4% | (5.0%) | 4.4% | (91.9%) | |
$16.9B | 6.8 | 34.6% | 19.9% | 25.6% | 17.0% | 9.6% | 56.1% | |
$14.7B | 8.7 | 56.2% | 23.9% | 30.2% | 18.4% | 28.1% | 152.6% | |
$10.4B | 4.0 | 48.0% | (12.7%) | (9.6%) | (14.6%) | 6.9% | (47.7%) | |
$9,757.8M | 7.3 | 48.7% | 14.1% | 21.1% | 10.5% | 9.7% | 93.3% |
The Predictive Oncology Inc. (POAI) gross profit margin is 7.9%, compared to the industry median of 48.0% and the 5-year historical average of 59.1%.
The Predictive Oncology Inc. (POAI) operating income margin is (954.2%), compared to the industry median of (7.6%)) and the 5-year historical average of (1,495.9%).
The Predictive Oncology Inc. (POAI) Free Cash Flow margin is (870.0%), compared to the industry median of 2.3% and the 5-year historical average of (851.0%).
The Predictive Oncology Inc. (POAI) earnings quality is 85.9%, compared to the industry median of 80.1% and the 5-year historical average of 61.5%.